A hybrid tissue engineering construct enabling sustained BMP2 delivery outperforms a clinically used collagen sponge in large bone defect repair: A preclinical study
Publication date: September 2026 Source: Biomedical Technology, Volume 15 Author(s): Hirotsugu Maekawa, Seyedsina Moeinzadeh, Elaine Lui, Tomohiro Uno, Hossein Vahid Alizadeh, Jiannan Li, Andrea Sofia Flores Perez, Richard Sammy Muniz, Sungwoo Kim, Ashley M. Potter, Chloe Brekhus, Dan Regan, Drew W. Koch, Masanori Kobayashi, Toshiyuki Kawai, Shuichi Matsuda, Ben Gadomski, Jeremiah T. Easley, Jeffrey L. Young, Michael Gardner
A hybrid tissue engineering construct enabling sustained BMP2 delivery outperforms a clinically used collagen sponge in large bone defect repair: A preclinical study. // Biomedical Technology. – URL: https://www.sciencedirect.com/science/article/pii/S2949723X26000358?dgcid=rss_sd_all
A hybrid tissue engineering construct enabling sustained BMP2 delivery outperforms a clinically used collagen sponge in large bone defect repair: A preclinical study. Biomedical Technology. https://www.sciencedirect.com/science/article/pii/S2949723X26000358?dgcid=rss_sd_all
“A hybrid tissue engineering construct enabling sustained BMP2 delivery outperforms a clinically used collagen sponge in large bone defect repair: A preclinical study.” Biomedical Technology.
@article{article37942,
title = {A hybrid tissue engineering construct enabling sustained BMP2 delivery outperforms a clinically used collagen sponge in large bone defect repair: A preclinical study},
journal = {Biomedical Technology},
url = {https://www.sciencedirect.com/science/article/pii/S2949723X26000358?dgcid=rss_sd_all}
}
Nature Biomedical Engineering, Published online: 18 November 2026; doi:10.1038/s41551-026-01843-z Tumour-associated mucins induce the disassembly of a designer PEGylated paclitaxel-conjugated nanomedicine into small unimers that escape...